Brief: Standard BioTools Enters Strategic Sale Of SomaLogic To Illumina
23/06/2025 12:11
June 23 (Reuters) - STANDARD BIOTOOLS- DEAL VALUED AT UP TO $425 MILLION WITH $350 MILLION UPFRONT STANDARD BIOTOOLS ENTERS NEXT PHASE OF TRANSFORMATION WITH STRATEGIC SALE OF SOMALOGIC TO ILLUMINA Source text: ID:nGNX14Dxx Further company coverage: ILMN.O ((reuters.briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsRoche launches Axelios gene sequencer in a bid to loosen Illumina's grip (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner